BIOCONNSEBiocon Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 14 Jan, 2026 · 23:51 IST

Biocon allots 11.27 cr shares at Rs 368.35 via QIP, raises Rs 4,150 cr

Marquee Qip InvestorFund Raising View source PDFExplain this filing

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.6%Reaction day
₹378.90
prior close
₹380.20
announcement price
After-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.0%-0.7% vs market
Pharmaceuticals peers, median of 156sector-0.8%+0.2% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Midcap 150 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
-0.1
15m
+0.4
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.6+0.0-0.7-0.8+0.2
Next day
-1.0-0.4-0.6-1.8+0.8
2d
-3.7-2.9-0.8-3.9+0.3
3d
-3.7-3.9+0.2-4.7+1.0
4d
-1.7-2.7+1.0-3.8+2.1
5d
-3.1-4.4+1.3-5.1+2.0
1w
-2.3-2.3-0.1-4.4+2.1
15d
-1.6+1.4-3.0-1.5-0.1
1m
+0.4+0.1+0.3-4.0+4.3
2m
-0.6-8.2+7.7-10.0+9.4
3m
-7.6-0.8-6.7-1.9-5.7
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biocon allotted 11.26 crore equity shares at Rs 368.35 per share to qualified institutional buyers, raising Rs 4,150 crore. The QIP opened Jan 12 and closed Jan 14, 2026. Major allottees were SBI Mutual Fund schemes (about 29.5 percent), ICICI Prudential funds (about 29.5 percent), and Mirae Asset funds (about 8.4 percent). Paid-up equity capital rose to Rs 810 crore from Rs 754 crore.

Likely market impact

Raises Rs 4,150 crore with about 7 percent equity dilution; reflects strong demand from top domestic mutual funds.